Ron Squarer has served as a director of Travere Therapeutics since April 2017. Since June 2023, Mr. Squarer has served as chair of the board of directors of Deciphera Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, where he has served as a director since December 2019. Mr. Squarer has also served as chair of the board […]